Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Hadi, Hamishehkar"'
Publikováno v:
Heliyon, Vol 10, Iss 15, Pp e35561- (2024)
Background: The COVID-19 pandemic has had a profound impact globally, presenting significant social and economic challenges. This study aims to explore the factors affecting mortality among hospitalized COVID-19 patients and construct a machine learn
Externí odkaz:
https://doaj.org/article/bcd9257499124aa2948df6727d221433
Autor:
Ata Mahmoodpoor, Afsaneh Farjami, Niloufar Farzan, Hamed Hamishehkar, Parina Asgharian, Sarvin Sanaie, Kamran Shadvar, Farnaz Naeimzadeh, Hadi Hamishehkar
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 13, Iss 1, Pp 143-149 (2023)
Purpose: Sepsis and systemic inflammatory response syndrome (SIRS) encompass various problems throughout the body, and two of its major problems are the creation of oxidative substances in the body and decrease of the body’s antioxidant capacity to
Externí odkaz:
https://doaj.org/article/d60ce5cd6cab42aaa0b5873d80b9cd4a
Autor:
Reza Ebrahimoghli, Ali Janati, Homayoun Sadeghi-Bazargani, Hadi Hamishehkar, Atefeh Khalili-Azimi
Publikováno v:
Iranian Journal of Medical Sciences, Vol 47, Iss 1, Pp 53-62 (2022)
Background: Cardiovascular disease (CVD) is the most prevalent comorbid condition among patients with diabetes. The objective of this study is to determine the incremental healthcare resource utilization and expenditures (HRUE) associated with CVD co
Externí odkaz:
https://doaj.org/article/31148f3821704e6189bc3c2472ede0d6
Publikováno v:
Journal of Pharmaceutical Care, Vol 10, Iss 2 (2022)
Background: Studies have shown that medication errors and adverse drug reactions are among the main causes of adverse events in hospitals leading to disability and death. Errors occur in the process of drug prescribing, dispensing, and administration
Externí odkaz:
https://doaj.org/article/4875d0dc92c54195a635d63da30e00a1
Publikováno v:
Journal of Pharmaceutical Care, Pp 70-74 (2020)
Background: Drug utilization review is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication. Vancomycin is a narrow-spectrum glycopeptide anti-infective with activity against many gram-positive organis
Externí odkaz:
https://doaj.org/article/da1431ec5ab4416ab7a53d4ee2df76c8
Publikováno v:
Journal of Pharmaceutical Care, Pp 57-64 (2020)
Background: Pharmacotherapy in elderly patients has become a major concern due to their physiological changes, pharmacokinetic and pharmacodynamics variations, poly-pharmacy, etc. Objective: According to the global population ageing, we aim to evalua
Externí odkaz:
https://doaj.org/article/fe33a99171454f5484593d4d6f42ce84
Publikováno v:
Journal of Pharmaceutical Care, Vol 9, Iss 4 (2021)
Background: Considering the high prevalence and risk of Deep Vein Thrombosis (DVT) and pulmonary thromboembolism (PTE) in hospitalized patients and the existence of different prophylaxis methods in these patients, the necessity of evaluating the rati
Externí odkaz:
https://doaj.org/article/686c736417004e8c9f47fd4505473910
Autor:
Taher Entezari Maleki, Haleh Rezaei, Hadi Hamishehkar, Afshin Gharekhani, Saba Ghaffari, Elnaz Shaseb, Behjat Pouriman
Publikováno v:
Taṣvīr-i salāmat, Vol 10, Iss 2, Pp 93-100 (2019)
Background and Objectives: Hypertension is one of the main risk factors of cardiovascular diseases and associated with mortality and morbidity all over the world. This study was designed to evaluate the rate of blood pressure (BP) control and its ass
Externí odkaz:
https://doaj.org/article/ff9ba8d0f91c4d3da82b5011daa5c9f6
Publikováno v:
Pharmaceutical Sciences, Vol 26, Iss Covid-19, Pp S49-S51 (2020)
Considering the recent controversies regarding the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Coronavirus disease 2019 (COVID-19) patients, and due to the limited published data in this field, we reviewed currently available evidence fo
Externí odkaz:
https://doaj.org/article/b0d4c2d24ea8442481e3ffa937bf56c8
Autor:
Ata Mahmoodpoor, Mahsa Medghalchi, Hossein Nazemiyeh, Parina Asgharian, Kamran Shadvar, Hadi Hamishehkar
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 8, Iss 2, Pp 347-351 (2018)
Purpose: Cucurbita maxima Duchense (C. maxima) has been widely used in China and Mexico as a hypoglycemic plant for controlling blood glucose in diabetic patients. Furthermore, in northwest of Iran, this plant is used traditionally for controlling of
Externí odkaz:
https://doaj.org/article/88619af39e52464b8295f2dc2de37952